Our Company

1-10 of 13

Cardiovascular event incidence and cost in type 2 diabetes: A commercial and Medicare claim based actuarial analysis10 August 2016 - By Helen E. Blumen and Kathryn V. Fitch and Tyler Engel - Article

An analysis to identify the annual rate and cost of cardiovascular (CV) events in patients with type 2 diabetes mellitus (T2DM) and the contribution of these CV events to both T2DM annual costs as well as total Medicare fee-for-service and commercially insured population annual costs.

Comparison of treatment costs for breast cancer, by tumor stage and type of service18 February 2016 - By Helen E. Blumen and Kathryn V. Fitch and Vincent Polkus - Article

The diagnosis of breast cancer at early stages is associated with better clinical and survival outcomes. But how the costs of care vary depending on the stage at which the disease was diagnosed have not been thoroughly examined.

Longitudinal commercial claims–based cost analysis of diabetic retinopathy screening patterns19 October 2015 - By Adam Turpcu and Helen E. Blumen and Kathryn V. Fitch and Purav Dave and Thomas Weisman and Tyler Engel and Yamina Rajput - Article

An analysis of the relationship between the frequency of retinopathy screening and the cost of care in adult patients with diabetes.

Utilization and cost of surgery for lumbar spinal stenosis in a commercially insured population13 October 2015 - By Helen E. Blumen and Kathryn V. Fitch and Tyler Engel - Article

An analysis of the frequency and cost of lumbar spinal stenosis-related decompression and lumbar fusion surgeries in a commercially insured population.

The burden of hepatitis C virus disease in commercial and managed Medicaid populations24 September 2015 - By Christine Ferro and Helen E. Blumen and Rebecca L. Johnson - Article

This study analyzes the burden of hepatitis C virus infection for a typical adult population in the United States, emphasizing actual costs and utilization rates for commercial insurers and managed Medicaid players.

Obesity in a commercially insured population: An analysis of NHANES data28 October 2014 - By Bruce S. Pyenson and Helen E. Blumen and Kathryn V. Fitch - Article

Analysis of NHANES data examines links between obesity and other medical conditions.

LTSS: The rebalancing imperative14 November 2013 - By Helen E. Blumen and Mat DeLillo - Article

How far can rebalancing go and at what point is it not economically rational?

National burden of preventable adverse drug events associated with inpatient injectable medications: Healthcare and medical professional liability costs10 December 2012 - By Betsy J. Lahue and Bruce S. Pyenson and Helen E. Blumen and Jeffrey M. Rothschild and Kosuke Iwasaki and Susan J. Forray - Article

What is the medical professional liability cost associated with preventable adverse drug effects?

CO-OPs and community health centers: Kindred spirits03 August 2012 - By Helen E. Blumen and Michael G. Sturm - Article
When CO-OPs should use community health centers to enroll members.Evidence-based guidelines: Essential building blocks for accountable care04 January 2011 - By Helen E. Blumen and Tiffanie Lenderman - Article
Evidence-based guidelines can create a central hub for ACO operations and information.
  • Work at Milliman

    • “I was offered a chance to come in, shake things up, create something."
    Work at Milliman